Expertise in
1
conditions

Jose J. Illarramendi

Complejo Hospitalario De Navarra
Pamplona, NC, ES 
Expertise in
1
conditions
Complejo Hospitalario De Navarra
Pamplona, NC, ES 

Overview

Jose Illarramendi practices practicing medicine in Pamplona, Spain.

Mr. Illarramendi is highly rated in 1 condition, according to our data. His clinical expertise encompasses Breast Cancer, COVID-19, Menopause, and Autosomal Recessive Hypotrichosis.

He is actively involved in clinical research, co-authoring 26 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Complejo Hospitalario de Navarra
Pamplona, NC 31008, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women With Endocrine Responsive Breast Cancer Who Desire Pregnancy
A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women With Endocrine Responsive Breast Cancer Who Desire Pregnancy
Enrollment Status: Active_not_recruiting
Publish Date: February 09, 2026
Intervention Type: Other
Study Phase: Not Applicable
Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial
Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial
Enrollment Status: Completed
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drugs: Elacestrant, Standard of Care
Study Phase: Phase 3
A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of Patients With HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 Therapies and Require Systemic Treatment
A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of Patients With HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 Therapies and Require Systemic Treatment
Enrollment Status: Completed
Publish Date: March 17, 2025
Intervention Type: Drug, Biological
Study Drugs: Margetuximab, Trastuzumab, Capecitabine, Eribulin, Gemcitabine, Vinorelbine
Study Phase: Phase 3
View 2 Less Clinical Trials

26 Total Publications

The Experience of Spanish Cancer Patients and Professionals With Quality of Life Assessment in Clinical Practice.
The Experience of Spanish Cancer Patients and Professionals With Quality of Life Assessment in Clinical Practice.
Journal: Journal of patient experience
Published: March 06, 2026

Frequently Asked Questions about Jose J. Illarramendi

Is Jose J. Illarramendi a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Jose J. Illarramendi is classified as an Advanced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jose J. Illarramendi participate in research or clinical trials?

Yes. Jose J. Illarramendi has published 26 articles and abstracts on conditions like Breast Cancer. You can view a list of Jose J. Illarramendi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Illarramendi's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile